PHAT icon

Phathom Pharmaceuticals
PHAT

Overview Fund Activity

114 hedge funds and large institutions have $588M invested in Phathom Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 35 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
-3
Holders Change %
-2.56%
% of All Funds
1.65%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.13%
New
13
Increased
40
Reduced
35
Closed
16
Calls
$811K
Puts
$991K
Net Calls
-$180K
Net Calls Change
-$518K

Top Buyers

1
MVM
1
Medicxi Ventures Management
Jersey
$79.3M
2
Jennison Associates
2
Jennison Associates
New York
$17.5M
3
PBM
3
Propel Bio Management
California
$9.24M
4
OCA
4
Octagon Capital Advisors
New York
$4.83M
5
6CM
5
683 Capital Management
New York
$17.5M

Top Sellers

1
TPC
1
Takeda Pharmaceutical Company
Japan
$33.5M
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$223K
3
WP
3
Woodline Partners
California
$6.02M
4
NM
4
Newtyn Management
New York
$1.75M
5
GGHC
5
Gilder Gagnon Howe & Co
New York
$10.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
AG
126
Algert Global
California
– -$136K -14,920 Closed
A
127
AlphaQuest
New York
– -$20.1K -2,205 Closed
Group One Trading
128
Group One Trading
Illinois
– -$14.1K -1,545 Closed
TWM
129
Tradition Wealth Management
Minnesota
– -$5K -500 Closed
2 3 4 5
6